NEW YORK - Sally Susman, Pfizer's executive VP and chief corporate affairs officer, will depart the pharmaceutical giant at ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Susman shared Tuesday that she’ll be stepping down from her role as EVP and chief corporate affairs officer after 18 years with the company. Susman joined Pfizer in 2007 and helped lead the company ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...

Executive Vice President and Chief Corporate Affairs Officer, Sally Susman, is leaving after serving the company for 18 long ...

Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

Susman is Pfizer’s Chief Corporate Affairs Officer and author of Breaking Through: Communicating to Open Minds, Move Hearts, and Change the World “She likes to be referred to formally, as Mrs ...

When it comes to delivering a message effectively, Pfizer’s Sally Susman has honed this crucial skill down to an art form. As the pharmaceutical giant’s executive vice president and chief ...

Investing.com -- Pfizer Inc. (NYSE:PFE) is undergoing a corporate restructuring that includes the departure of Sally Susman, the company’s chief corporate affairs officer who has managed public ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years. Read more here.